2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In black African children with focal segmental glomerulosclerosis (FSGS) there are high rates of steroid resistance. The aim was to determine genetic associations with apolipoprotein L1 ( APOL1) renal risk variants and podocin ( NPHS2) variants in 30 unrelated black South African children with FSGS. Three APOL1 variants were genotyped and the exons of the NPHS2 gene sequenced in the cases and controls. APOL1 risk alleles show a modest association with steroid sensitive nephrotic syndrome (SSNS) and steroid resistant nephrotic syndrome (SRNS). The NPHS2 V260E variant was present in SRNS cases (V/V = 5; V/E = 4; E/E = 11), and was absent in SSNS cases. Haplotype analysis suggests a single mutation origin for V260E and it was associated with a decline in kidney function over a 60-month period (p = 0.026). The V260E variant is a good predictor of autosomal recessive SRNS in black South African children and could provide useful information in a clinical setting.

          Abstract

          Govender et al. report that the common African mutation V260E in the podocin protein is associated with autosomal recessive steroid resistant nephrotic syndrome in black South African children with biopsy-proven focal segmental glomerulosclerosis. This variant was absent in children with steroid sensitive nephrotic syndrome, indicating its utility in treatment decisions.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

          Familial idiopathic nephrotic syndromes represent a heterogeneous group of kidney disorders, and include autosomal recessive steroid-resistant nephrotic syndrome, which is characterized by early childhood onset of proteinuria, rapid progression to end-stage renal disease and focal segmental glomerulosclerosis. A causative gene for this disease, NPHS2, was mapped to 1q25-31 and we report here its identification by positional cloning. NPHS2 is almost exclusively expressed in the podocytes of fetal and mature kidney glomeruli, and encodes a new integral membrane protein, podocin, belonging to the stomatin protein family. We found ten different NPHS2 mutations, comprising nonsense, frameshift and missense mutations, to segregate with the disease, demonstrating a crucial role for podocin in the function of the glomerular filtration barrier.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            APOL1 kidney risk alleles: population genetics and disease associations.

            APOL1 kidney disease is a unique case in the field of the genetics of common disease: 2 variants (termed G1 and G2) with high population frequency have been repeatedly associated with nondiabetic CKDs, with very strong effect size (odds ratios 3-29) in populations of sub-Saharan African descent. This review provides an update on the spectrum of APOL1 kidney disease and on the worldwide distribution of these kidney risk variants. We also summarize the proper way to run a recessive analysis on joint and independent effects of APOL1 G1 and G2 kidney risk variants.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

              Mapping by admixture linkage disequilibrium (LD) detected strong association between nonmuscle myosin heavy chain 9 gene (MYH9) variants on chromosome 22 and nondiabetic nephropathy in African Americans. MYH9-related variants were posited to be the probable, but not necessarily the definitive, causal variants as a result of impressive statistical evidence of association, renal expression, and a role in autosomal dominant MYH9 disorders characterized by progressive glomerulosclerosis (Epstein and Fechtner syndromes). Dense mapping within MYH9 revealed striking LD patterns and racial variation in risk allele frequencies, suggesting population genetic factors such as selection may be operative in this region. Genovese and colleagues examined large chromosomal regions adjacent to MYH9 using genome-wide association methods and non-HapMap single nucleotide polymorphisms identified in Yoruba from the 1000 Genomes project. Statistically stronger associations were detected between two independent sequence variants in the Apolipoprotein L1 gene (APOL1) and nondiabetic nephropathy in African Americans, with odds ratios of 10.5 in idiopathic FSGS and 7.3 in hypertension-attributed ESRD. These kidney disease risk variants likely rose to high frequency in Africa because they confer resistance to trypanosomal infection and protect from African sleeping sickness. Risk variants in MYH9 and APOL1 are in strong LD, and the genetic risk that was previously attributed to MYH9 may reside, in part or in whole, in APOL1, although more complex models of risk cannot be excluded. This association likely explains racial disparities in nondiabetic nephropathy as a result of the high prevalence of risk alleles in individuals of African ancestry.
                Bookmark

                Author and article information

                Contributors
                michele.ramsay@wits.ac.za
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                15 November 2019
                15 November 2019
                2019
                : 2
                : 416
                Affiliations
                [1 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Sydney Brenner Institute for Molecular Bioscience and Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, , University of the Witwatersrand, ; Johannesburg, South Africa
                [2 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Wits Donald Gordon Medical Centre, , University of the Witwatersrand, ; Johannesburg, South Africa
                [3 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Division of Nephrology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, , University of the Witwatersrand, ; Johannesburg, South Africa
                [4 ]ISNI 0000 0001 2107 2298, GRID grid.49697.35, Department of Paediatrics, , University of Pretoria, ; Pretoria, South Africa
                [5 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Nelson Mandela Children’s Hospital, Division of Nephrology, Department of Paediatrics, School of Clinical Medicine, Faculty of Health Sciences, , University of the Witwatersrand, ; Johannesburg, South Africa
                [6 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Charlotte Maxeke Johannesburg Academic Hospital, Division of Nephrology, Department of Paediatrics, Faculty of Health Sciences, , University of the Witwatersrand, ; Johannesburg, South Africa
                [7 ]ISNI 0000 0004 0535 8394, GRID grid.418021.e, Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Leidos Biomedical Research, Inc., , Frederick National Laboratory, ; Frederick, MD USA
                Author information
                http://orcid.org/0000-0001-5552-0917
                http://orcid.org/0000-0002-4156-4801
                Article
                658
                10.1038/s42003-019-0658-1
                6858321
                ce5debaf-b58a-4c9a-9904-ecea727c60a5
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 27 February 2019
                : 22 October 2019
                Funding
                Funded by: NRF funding
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                genetics,molecular medicine
                genetics, molecular medicine

                Comments

                Comment on this article